Genome-wide  ||| S:0 E:12 ||| JJ
case-control  ||| S:12 E:25 ||| JJ
study  ||| S:25 E:31 ||| NN
of  ||| S:31 E:34 ||| IN
musculoskeletal  ||| S:34 E:50 ||| JJ
adverse  ||| S:50 E:58 ||| JJ
events  ||| S:58 E:65 ||| NNS
and  ||| S:65 E:69 ||| CC
functional  ||| S:69 E:80 ||| JJ
genomics  ||| S:80 E:89 ||| NN
in  ||| S:89 E:92 ||| IN
women  ||| S:92 E:98 ||| NNS
receiving  ||| S:98 E:108 ||| VBG
aromatase  ||| S:108 E:118 ||| JJ
inhibitors ||| S:118 E:128 ||| NN
:  ||| S:128 E:130 ||| :
going  ||| S:130 E:136 ||| VBG
beyond  ||| S:136 E:143 ||| IN
associations  ||| S:143 E:157 ||| NNS
